Stress - Tension
- Manufacturer
- Newton Laboratories, Inc.
- Effective date
- 2011-03-01
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 02:05:00
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
INDICATIONS & USAGE SECTION
Stress~Tension Formulated for associated symptoms such as worry, frustration, emotional sensitivity and the feeling of being mentally and physically drained.
DOSAGE & ADMINISTRATION SECTION
Directions: Ages 12 and up, take 6 pellets orally (ages 0 to 11, give 3 pellets) as needed or as directed by a healthcare professional. Under age 2, crush or dissolve pellets in purified water. Sensitive persons begin with 1 pellet and gradually increase to full dose.
OTC - ACTIVE INGREDIENT SECTION
Aconitum nap. 15x, Arg. nit. 15x, Aur.met. 15x, Baptisia 15x, Bryonia 15x, Chelidonium majus 15x, Cimicifuga 15x, Conium 15x, Gelsemium 15x, Ignatia 15x, Kali carb.15x, Lachesis 15x, Lilium 15x, Lycopodium 15x, Nat. carb. 15x, Nat.mur. 15x, Phosphoricum ac. 15x, Phosphorus 15x, Picricum ac. 15x, Plumb. met. 15x, Sepia 15x, Staphysag. 15x, Stramonium 15x, Thuja occ. 15x, Zinc. met. 15x, Chamomilla 3x, Hypericum 3x, Valeriana 3x.
OTC - PURPOSE SECTION
Formulated for associated symptoms such as worry, frustration, emotional sensitivity and the feeling of being mentally and physically drained.
INACTIVE INGREDIENT SECTION
Inactive Ingredients: Gluten-free, non-GMO, beet-derived sucrose pellets.
QUESTIONS SECTION
www.newtonlabs.net Newton Laboratories, Inc. FDA Est # 1051203 - Conyers, GA 30012
Questions? 1.800.448.7256
WARNINGS SECTION
Warning: Do not use if tamper - evident seal is broken or missing. Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days. Keep out of reach of children.
OTC - PREGNANCY OR BREAST FEEDING SECTION
Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
PACKAGE LABEL
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 55714-2331-0 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-ffe9-f424-e053-dadaa90a57ce | Stress - Tension |
| 55714-2331-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-ffe9-f424-e053-dadaa90a57ce | Stress - Tension |
| 55714-2331-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-ffe9-f424-e053-dadaa90a57ce | Stress - Tension |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55714-2331-0 | Stress - Tension | 7.08 g in 1 BOTTLE, GLASS | PELLET | 7.08 | 1 | |
| 55714-2331-1 | Stress - Tension | 28.35 g in 1 BOTTLE, GLASS | PELLET | 28.35 | 1 | |
| 55714-2331-2 | Stress - Tension | 56.7 g in 1 BOTTLE, GLASS | PELLET | 56.7 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 55714-2331 | STRESS - TENSION (ACONITUM NAP., ARG. NIT., AUR.MET., BAPTISIA, BRYONIA, CHELIDONIUM MAJUS, CIMICIFUGA, CONIUM, GELSEMIUM, IGNATIA, KALI CARB., LACHESIS, LILIUM, LYCOPODIUM, NAT. CARB., NAT.MUR., PHOSPHORICUM AC., PHOSPHORUS, PICRICUM AC., PLUMB. MET., SEPIA, STAPHYSAG., STRAMONIUM, THUJA OCC., ZINC. MET., CHAMOMILLA, HYPERICUM, VALERIANA) PELLET [NEWTON LABORATORIES, INC.] | 1 | Legacy NDC, 3 package rows | 20131015_47a72fe2-e10f-3fa1-7e08-411b743035ca.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Aconitum Napellus | ACTIVE INGREDIENT | U0NQ8555JD | 1 | |
| Baptisia Tinctoria | ACTIVE INGREDIENT | 5K1UO2888Y | 1 | |
| Black Cohosh | ACTIVE INGREDIENT | K73E24S6X9 | 1 | |
| Bryonia Alba Root | ACTIVE INGREDIENT | T7J046YI2B | 1 | |
| Chelidonium Majus | ACTIVE INGREDIENT | 7E889U5RNN | 1 | |
| Conium Maculatum Flowering Top | ACTIVE INGREDIENT | Q28R5GF371 | 1 | |
| Datura Stramonium | ACTIVE INGREDIENT | G6W4F0V8Z3 | 1 | |
| Delphinium Staphisagria Seed | ACTIVE INGREDIENT | 00543AP1JV | 1 | |
| Gelsemium Sempervirens Root | ACTIVE INGREDIENT | 639KR60Q1Q | 1 | |
| Gold | ACTIVE INGREDIENT | 79Y1949PYO | 1 | |
| Hypericum Perforatum | ACTIVE INGREDIENT | XK4IUX8MNB | 1 | |
| Lachesis Muta Venom | ACTIVE INGREDIENT | VSW71SS07I | 1 | |
| Lead | ACTIVE INGREDIENT | 2P299V784P | 1 | |
| Lilium Lancifolium Whole Flowering | ACTIVE INGREDIENT | X67Z2963PI | 1 | |
| Lycopodium Clavatum Spore | ACTIVE INGREDIENT | C88X29Y479 | 1 | |
| Matricaria Recutita | ACTIVE INGREDIENT | G0R4UBI2ZZ | 1 | |
| Phosphoric Acid | ACTIVE INGREDIENT | E4GA8884NN | 1 | |
| Phosphorus | ACTIVE INGREDIENT | 27YLU75U4W | 1 | |
| Potassium Carbonate | ACTIVE INGREDIENT | BQN1B9B9HA | 1 | |
| Sepia Officinalis Juice | ACTIVE INGREDIENT | QDL83WN8C2 | 1 | |
| Silver Nitrate | ACTIVE INGREDIENT | 95IT3W8JZE | 1 | |
| Sodium Carbonate | ACTIVE INGREDIENT | 45P3261C7T | 1 | |
| Sodium Chloride | ACTIVE INGREDIENT | 451W47IQ8X | 1 | |
| Strychnos Ignatii Seed | ACTIVE INGREDIENT | 1NM3M2487K | 1 | |
| Thuja Occidentalis Leafy Twig | ACTIVE INGREDIENT | 1NT28V9397 | 1 | |
| Trinitrophenol | ACTIVE INGREDIENT | A49OS0F91S | 1 | |
| Valerian | ACTIVE INGREDIENT | JWF5YAW3QW | 1 | |
| Zinc | ACTIVE INGREDIENT | J41CSQ7QDS | 1 | |
| Aconitum Napellus | ACTIVE MOIETY | U0NQ8555JD | 1 | |
| Baptisia Tinctoria | ACTIVE MOIETY | 5K1UO2888Y | 1 | |
| Black Cohosh | ACTIVE MOIETY | K73E24S6X9 | 1 | |
| Bryonia Alba Root | ACTIVE MOIETY | T7J046YI2B | 1 | |
| Carbonate Ion | ACTIVE MOIETY | 7UJQ5OPE7D | 1 | |
| Chelidonium Majus | ACTIVE MOIETY | 7E889U5RNN | 1 | |
| Chloride Ion | ACTIVE MOIETY | Q32ZN48698 | 1 | |
| Conium Maculatum Flowering Top | ACTIVE MOIETY | Q28R5GF371 | 1 | |
| Datura Stramonium | ACTIVE MOIETY | G6W4F0V8Z3 | 1 | |
| Delphinium Staphisagria Seed | ACTIVE MOIETY | 00543AP1JV | 1 | |
| Gelsemium Sempervirens Root | ACTIVE MOIETY | 639KR60Q1Q | 1 | |
| Gold | ACTIVE MOIETY | 79Y1949PYO | 1 | |
| Hypericum Perforatum | ACTIVE MOIETY | XK4IUX8MNB | 1 | |
| Lachesis Muta Venom | ACTIVE MOIETY | VSW71SS07I | 1 | |
| Lead | ACTIVE MOIETY | 2P299V784P | 1 | |
| Lilium Lancifolium Whole Flowering | ACTIVE MOIETY | X67Z2963PI | 1 | |
| Lycopodium Clavatum Spore | ACTIVE MOIETY | C88X29Y479 | 1 | |
| Matricaria Recutita | ACTIVE MOIETY | G0R4UBI2ZZ | 1 | |
| Phosphoric Acid | ACTIVE MOIETY | E4GA8884NN | 1 | |
| Phosphorus | ACTIVE MOIETY | 27YLU75U4W | 1 | |
| Picric Acid | ACTIVE MOIETY | A49OS0F91S | 1 | |
| Sepia Officinalis Juice | ACTIVE MOIETY | QDL83WN8C2 | 1 | |
| Silver Cation | ACTIVE MOIETY | 57N7B0K90A | 1 | |
| Strychnos Ignatii Seed | ACTIVE MOIETY | 1NM3M2487K | 1 | |
| Thuja Occidentalis Leafy Twig | ACTIVE MOIETY | 1NT28V9397 | 1 | |
| Valerian | ACTIVE MOIETY | JWF5YAW3QW | 1 | |
| Zinc | ACTIVE MOIETY | J41CSQ7QDS | 1 | |
| Sucrose | INACTIVE INGREDIENT | C151H8M554 | 1 |
Products#
Every source-derived product name is available through these pages.
- Stress - Tension
- Aconitum nap., Arg. nit., Aur.met., Baptisia, Bryonia, Chelidonium majus, Cimicifuga, Conium, Gelsemium, Ignatia, Kali carb., Lachesis, Lilium, Lycopodium, Nat. carb., Nat.mur., Phosphoricum ac., Phosphorus, Picricum ac., Plumb. met., Sepia, Staphysag., Stramonium, Thuja occ., Zinc. met., Chamomilla, Hypericum, Valeriana
- Aconitum Napellus
- Silver Nitrate
- Silver Cation
- Gold
- Baptisia Tinctoria
- Bryonia Alba Root
- Chelidonium Majus
- Black Cohosh
- Conium Maculatum Flowering Top
- Gelsemium Sempervirens Root
- Strychnos Ignatii Seed
- Potassium Carbonate
- Carbonate Ion
- Lachesis Muta Venom
- Lilium Lancifolium Whole Flowering
- Lycopodium Clavatum Spore
- Sodium Carbonate
- Sodium Chloride
- Chloride Ion
- Phosphoric Acid
- Phosphorus
- Trinitrophenol
- Picric Acid
- Lead
- Sepia Officinalis Juice
- Delphinium Staphisagria Seed
- Datura Stramonium
- Thuja Occidentalis Leafy Twig
- Zinc
- Matricaria Recutita
- Hypericum Perforatum
- Valerian
- Sucrose
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 55714-2331 | 55714-2331-1, 55714-2331-2, 55714-2331-0 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Sucrose | SUCROSE | C151H8M554 | SUPPOSITORY / RECTAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, CHEWABLE / ORAL | 7258 mg | ||
| Sucrose | SUCROSE | C151H8M554 | POWDER, FOR SUSPENSION / ORAL | 40017 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 86 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, FILM COATED / ORAL | 145 mg | ||
| Sucrose | SUCROSE | C151H8M554 | WAFER / ORAL | 155.2 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 900 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SOLUTION / ORAL | 70000 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SUSPENSION/ DROPS / ORAL | 3750 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SYRUP / ORAL | 46400 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION / INTRAVENOUS | 1950 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, SOLUTION / INTRAVENOUS | NA | ||
| Sucrose | SUCROSE | C151H8M554 | SUSPENSION / ORAL | 48209 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET / BUCCAL | 109 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, EMULSION / INTRAVENOUS | 970 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TROCHE / BUCCAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | GRANULE, FOR SOLUTION / ORAL | 42596 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION / SUBCUTANEOUS | 47.75 mg | ||
| Sucrose | SUCROSE | C151H8M554 | POWDER / ORAL | 27768 mg | ||
| Sucrose | SUCROSE | C151H8M554 | POWDER, FOR SOLUTION / ORAL | 38666 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE / ORAL | 3568 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE, DELAYED RELEASE / ORAL | 955 mg | ||
| Sucrose | SUCROSE | C151H8M554 | LIQUID / ORAL | 37500 mg | ||
| Sucrose | SUCROSE | C151H8M554 | GRANULE / ORAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE, COATED PELLETS / ORAL | 59.8 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SUSPENSION, EXTENDED RELEASE / ORAL | 5400 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CONCENTRATE / ORAL | 4800 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET / ORAL | 4249 mg | ||
| Sucrose | SUCROSE | C151H8M554 | PASTILLE / ORAL | 426 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SOLUTION / RECTAL | 35.42 %w/v | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 119.12 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE, EXTENDED RELEASE / ORAL | 619 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS | 9.4 %w/v | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS | 308 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, DELAYED RELEASE / ORAL | 295.33 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET / SUBLINGUAL | 109 mg | ||
| Sucrose | SUCROSE | C151H8M554 | DROPS / ORAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | 1 mg | ||
| Sucrose | SUCROSE | C151H8M554 | LOZENGE / BUCCAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | LOZENGE / TRANSMUCOSAL | 1255 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, COATED / ORAL | 516.42 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 2000 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TROCHE / ORAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | ELIXIR / ORAL | 18000 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, EXTENDED RELEASE / ORAL | 284.54 mg | ||
| Sucrose | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | 18790 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTABLE, LIPOSOMAL / INTRAVENOUS | 7560 mg | ||
| Sucrose | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION / ORAL | 31885 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 65002e3c-9fec-6ac0-441a-bcbed02ecea9 | 47a72fe2-e10f-3fa1-7e08-411b743035ca | 2011-03-01 | Warnings | 65002e3c-9fec-6ac0-441a-bcbed02ecea9 47a72fe2-e10f-3fa1-7e08-411b743035ca |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
